As of July 17, 2024, the estimated net worth of J Michael Cline stands at $0. Known for his significant stake in NeoMedia Technologies Inc., Cline’s current financial status reflects his holdings, which are now valued at $0 due to his lack of shares in the company. Here’s a closer look at the factors influencing Michael Cline’s net worth.
Who is J Michael Cline?
J Michael Cline is a notable figure in the financial and technology sectors, recognized for his involvement with NeoMedia Technologies Inc. Despite his past ownership, recent reports indicate that he no longer holds any shares in the company. This change is reflected in the current net worth estimation, which is based on SEC filings and indicates no recent stock transactions since March 18, 2011.
What is NeoMedia Technologies Inc and Its Impact on Michael Cline’s Net Worth?
NeoMedia Technologies Inc. is a company that played a key role in developing mobile barcode technology. Although the company has been innovative, its stock performance has struggled, which has impacted Michael Cline’s net worth. The company’s stock value, and Cline’s financial interest, has not improved since his last recorded transactions.
How Accurate are Insider Trading Reports?
Insider trading reports provide insights based on SEC filings, reflecting the most recent stock transactions and holdings. For J Michael Cline, the net worth calculation is based on these reports, which show no transactions since 2011. This accuracy is contingent on the timeliness of the filings and whether any new transactions have occurred since the last update.
What is the Trading Activity at Accolade?
Over the past four years, insiders at Accolade, Inc. have traded over $9 million worth of stock. Key figures in these transactions include Edgar Jr Bronfman, Jeffrey D Jordan, and Dawn G Lepore. The most recent trade involved Stephen H. Barnes, who traded 770 units of ACCD stock on July 10, 2024, valued at $2,957.
Who are the Most Active Insiders at Accolade?
The most active insiders at Accolade include Edgar Jr Bronfman, Jeffrey D Jordan, and Dawn G Lepore. These individuals have been highly engaged in trading activities, with transactions occurring approximately every five days and averaging around $19,334 per trade. Their frequent trading impacts the company’s stock and provides valuable insights into its financial health.
What Does Accolade Do?
Accolade, Inc. is a company specializing in technology-enabled solutions that assist individuals in navigating the healthcare system and workplace benefits in the U.S. Their platform combines cloud-based technology with support from healthcare professionals, including nurses, physicians, and behavioral health specialists. Accolade also offers second opinion consultations and decision support services to improve healthcare experiences.
How Does Accolade Support Employers and Employees?
Accolade’s services are designed to simplify healthcare management for employees while providing employers with a comprehensive solution to support their workforce. The company’s platform offers personalized guidance and assistance, aiming to enhance healthcare outcomes and streamline benefits management.
What is the History and Location of Accolade?
Founded in 2007, Accolade, Inc. is headquartered in Plymouth Meeting, Pennsylvania. The company’s mission is to deliver thorough support to individuals navigating the complexities of healthcare, ensuring they receive the best possible care and benefits.
What are the Recent Developments at Accolade?
Accolade has been focused on expanding its services and enhancing its platform to better meet the needs of its clients. Recent stock trades and ongoing innovations in the healthcare sector highlight Accolade’s commitment to improving healthcare navigation and benefits management.
Why is Insider Trading Information Important?
Insider trading information offers valuable insights into the buying and selling activities of a company’s executives and directors. For investors, this information reflects the confidence and outlook of those most familiar with the company’s operations, making it a crucial factor in investment decisions.
Conclusion
As of mid-2024, Michael Cline’s net worth is reported to be $0 due to his current lack of holdings in NeoMedia Technologies Inc. Meanwhile, Accolade continues to progress in the healthcare sector, with active insider trading and a strong focus on enhancing healthcare navigation and benefits management. These developments underscore the dynamic nature of both individual financial standings and corporate advancements in the business landscape.